Balance on slack line; diagnostic intensity and patient safety during the SARS-CoV-2 pandemic

References

• Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239.
   PubMed Web of Science ®Google Scholar
• Maluchnik M, Podwójcic K, Więckowska B. Measurable externalities of COVID-19 social distancing policy: limited access to cancer diagnosis and treatment in Poland. Acta Oncol. 2021.
   PubMed Web of Science ®Google Scholar
• Jeppesen SS, Bentsen KK, Jorgensen TL, et al. Quality of life in patients with cancer during the COVID-19 pandemic - a Danish cross-sectional study (COPICADS). Acta Oncol. 2021;1–9.
   PubMed Web of Science ®Google Scholar
• Höllein A, Bojko P, Schulz S, et al. Characteristics and outcomes of patients with cancer and COVID-19: results form a cohort study. Acta Oncol. 2021.
   PubMed Web of Science ®Google Scholar
• Larfors G, Pahnke S, State M, et al. Covid-19 intensive care admissions and mortality among Swedish patients with cancer. Acta Oncol. 2021.
   PubMed Web of Science ®Google Scholar
• Skovlund CW, Friis S, Dehlendorff C, et al. Hidden morbidities: drop in cancer diagnoses during the COVID-19 pandemic in Denmark. Acta Oncol. 2020;1–4. DOI:10.1080/0284186X.2020.1858235
   PubMed Web of Science ®Google Scholar
• Park R, Lee SA, Kim SY, et al. Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient data. Acta Oncol. 2021. DOI:10.1080/0284186X.2020.1837946
   PubMed Web of Science ®Google Scholar
• ElGohary GM, Hashmi S, Styczynski J, et al. The risk and prognosis of COVID-19 infection in cancer patients: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther. 2020. DOI:10.1016/j.hemonc.2020.07.005
   PubMedGoogle Scholar
• Zhang H, Han H, He T, et al. Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2020. DOI:10.1093/jnci/djaa168
   Google Scholar
• Brar G, Pinheiro LC, Shusterman M, et al. COVID-19 severity and outcomes in patients with cancer: a matched cohort study. J Clin Oncol. 2020;38(33):3914–3924.
   PubMed Web of Science ®Google Scholar
• Reilev M, Kristensen KB, Pottegard A, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020;49(5):1468–1481.
   PubMed Web of Science ®Google Scholar
• Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436.
   PubMed Web of Science ®Google Scholar
• Glenthoj A, Jakobsen LH, Sengelov H, et al. SARS-CoV-2 infection among patients with haematological disorders: severity and one-month outcome in 66 Danish patients in a nationwide cohort study. Eur J Haematol. 2021;106(1):72–81.
   PubMed Web of Science ®Google Scholar
• Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7(10):e737–e745.
   PubMed Web of Science ®Google Scholar
• García-Suárez J, de la Cruz J, Cedillo Á, et al. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol. 2020;13(1):133.
   PubMed Web of Science ®Google Scholar
• Lee LYW, Cazier JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–1316.
   PubMed Web of Science ®Google Scholar
• Chari A, Samur MK, Martinez-Lopez J, et al. Clinical features associated with COVID-19 outcome in MM: first results from International Myeloma Society Dataset. Blood. 2020;136(26):3033–3040.
   Web of Science ®Google Scholar
• Cattaneo C, Daffini R, Pagani C, et al. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19. Cancer. 2020;126(23):5069–5076.
   PubMed Web of Science ®Google Scholar
• Luo J, Rizvi H, Preeshagul IR, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):1386–1396.
   PubMed Web of Science ®Google Scholar
• Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023–1034.
   PubMed Web of Science ®Google Scholar
• Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020;21(8):1035–1044.
   PubMed Web of Science ®Google Scholar
• Hamilton W. Cancer diagnostic delay in the COVID-19 era: what happens next? Lancet Oncol. 2020;21(8):1000–1002.
   PubMed Web of Science ®Google Scholar
• Jones D, Neal RD, Duffy SRG, et al. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. Lancet Oncol. 2020;21(6):748–750.
   PubMed Web of Science ®Google Scholar
• Gray DP, Sidaway-Lee K, Harding A, et al. Reduction in face-to-face GP consultations. Br J Gen Pract. 2020;70(696):328.
   PubMed Web of Science ®Google Scholar
• Menon U, Vedsted P, Zalounina Falborg A, et al. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. 2019;9(11):e025895.
   PubMed Web of Science ®Google Scholar
• Weller D, Menon U, Zalounina Falborg A, et al. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP). BMJ Open. 2018;8(11):e023870.
   PubMed Web of Science ®Google Scholar
• Jensen H, Torring ML, Olesen F, et al. Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study. BMC Cancer. 2014;14:636.
   PubMed Web of Science ®Google Scholar
• Helsper CW, Campbell C, Emery J, et al. Cancer has not gone away: a primary care perspective to support a balanced approach for timely cancer diagnosis during COVID-19. Eur J Cancer Care. 2020;29(5):e13290.
   PubMed Web of Science ®Google Scholar